Pentixapharm Holding AG (Frankfurt Prime Standard: PTP), a clinical-stage biotech developing novel radiopharmaceuticals, today announced that the U.S. Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application for…
With the groundbreaking of the Berlin Center for Gene and Cell Therapies and the opening of the Berlin Center for Advanced Therapies at Charité, Berlin-Brandenburg is stepping up efforts to position itself as a leading location for advanced and…
Application deadline 30 June 2026
Science Meets Strategy – A Decade of Innovation, Collaboration and Impact HTW Berlin – University of Applied Sciences marked a decade of its international Master's programme MBA & Engineering in Life Science Management (LSM) by bringing together…
Michael Gotthardt and his team have discovered a previously unknown genetic switch that affects RBM20, an important protein in heart cells. The findings, published in “Nature Communications,” suggest a potential new target for treating…
EU project aims to make breakthrough in sustainable chemical manufacture
Early-stage and incorporated high-potential AI startups based in Germany can now apply for the next AI Nation Grant and the next AI Nation Accelerator batch.
T-CURX acquires Pantherna Therapeutics to leverage the complementary expertises and proprietary technologies of both companies to accelerate clinical translation of CAR-T strategies with a clear focus on clinical validation of in vivo CAR-T…
Eckert & Ziegler SE (ISIN DE0005659700) has won the “Best Managed Companies Award” for the third time in a row. With this honor, Deloitte Private, UBS, Frankfurter Allgemeine Zeitung, and the Federation of German Industries (BDI) recognize…
A combination of three drugs appears to more effectively treat people with cystic fibrosis than therapy with only two, concludes a study by Max Delbrück Center researchers published in “Cell Systems.” The study analyzed changes in the proteomes of…
